Vistagen Therapeutics, Inc. - Common Stock (NQ:VTGN)

0.2810 -0.0016 (-0.57%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vistagen Therapeutics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

16 17 Next >

Vistagen Regains Full Compliance with Nasdaq Listing Requirements

June 23, 2023

From Vistagen

Via Business Wire

InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Eyes Advancement of Itruvone into Phase 2B Development

June 21, 2023

Via Investor Brand Network

Vistagen Announces Results of Successful U.S. Phase 1 Study of Itruvone (PH10), Enabling U.S. Phase 2B Development for Treatment of Major Depressive Disorder

June 21, 2023

From Vistagen

Via Business Wire

Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗

June 21, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

InvestorNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Announces Participation in Upcoming Maxim Group Healthcare Virtual Conference

June 16, 2023

Via Investor Brand Network

Vistagen to Participate in the Maxim Group Healthcare Virtual Conference Hosted by M-Vest

June 16, 2023

From Vistagen

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

June 15, 2023

On Thursday, 64 companies achieved new lows for the year.

Via Benzinga

InvestorNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) PH80 Nasal Spray to Receive EPO Patent Approval

June 13, 2023

Via Investor Brand Network

Topics Intellectual Property

Vistagen Announces European Patent Office Intention to Grant New PH80 Nasal Spray Patent for the Treatment of Migraine

June 13, 2023

From Vistagen

Via Business Wire

InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Positive Results from PH80 Exploratory Phase 2A Study

June 08, 2023

Via Investor Brand Network

Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 07, 2023

Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for...

Via Benzinga

Vistagen's Nasal Spray Shows Efficacy In Menopausal Hot Flashes ↗

June 07, 2023

Vistagen Therapeutics Inc (NASDAQ: VTGN) announced that PH80, one of the Company's five investigational neuroactive nasal sprays, demonstrated statistically significant efficacy versus placebo in an...

Via Benzinga

InvestorNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) to Participate in Upcoming Jefferies Global Healthcare Conference

June 07, 2023

Via Investor Brand Network

Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH80 in Women Diagnosed with Menopausal Hot Flashes

June 07, 2023

From Vistagen

Via Business Wire

Vistagen to Present at Jefferies 2023 Global Healthcare Conference

June 06, 2023

From Vistagen

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 06, 2023

Via Benzinga

InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) to Implement Board-Approved Reverse Stock Split

June 06, 2023

Via Investor Brand Network

Vistagen Announces Stockholder-Approved Reverse Stock Split

June 06, 2023

From Vistagen

Via Business Wire

InvestorNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Presents Phase 3 SAD Study Results at ASCP Annual Meeting

June 01, 2023

Via Investor Brand Network

Vistagen Presents Fasedienol (PH94B) Safety and Exploratory Efficacy Data from Phase 3 Open-Label Social Anxiety Disorder Study at American Society for Clinical Psychopharmacology Annual Meeting

June 01, 2023

From Vistagen

Via Business Wire

Crude Oil Down 2%; Donaldson Shares Drop Following Q3 Results ↗

May 31, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 100 points on Wednesday. The Dow traded down 0.34% to 32,929.04 while the NASDAQ fell 0.30% to 12,978.20. The S&P...

Via Benzinga

Nasdaq Down 100 Points; Advance Auto Parts Earnings Miss Views ↗

May 31, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded down 0.82% to 32,773.27 while the NASDAQ fell 0.86% to 12,905.49. The...

Via Benzinga

Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 31, 2023

Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of...

Via Benzinga

InvestorNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) to Report Phase 3 Study Results at Upcoming ASCP Annual Meeting

May 31, 2023

Via Investor Brand Network

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 31, 2023

Via Benzinga

Why LL Flooring Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket ↗

May 31, 2023

Gainers VIQ Solutions Inc. (NASDAQ: VQS) shares rose 66.8% to $0.3887 in pre-market trading.

Via Benzinga

Vistagen to Present Fasedienol (PH94B) Safety and Exploratory Efficacy Data from Phase 3 Open-Label Social Anxiety Disorder Study at American Society for Clinical Psychopharmacology Annual Meeting

May 30, 2023

From Vistagen

Via Business Wire

InvestorNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Recognized with MHA Platinum Bell Seal for Workplace Mental Health

May 24, 2023

Via Investor Brand Network

Vistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health

May 24, 2023

From Vistagen

Via Business Wire

Vistagen Presents New Fasedienol (PH94B) Research at 2023 Anxiety and Depression Association of America Conference

April 19, 2023

From Vistagen

Via Business Wire

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.